Free · 13,591 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Safety & Evidence

Efficacy and Safety of Photobiomodulation in MELAS: Protocol for a Series of N-of-1 Trials

Hydrogen magnetic resonance spectra will be acquired and averaged to obtain the content of the targeted hydrogen levels. Discussion: The study will provide guidance on whether and how to progress to a larger, randomised cohort study with sham control.

Excerpt from the paper’s abstract. Read the full paper for the details.

AI-generated summary

The authors describe a protocol for a pilot series of N-of-1 trials testing home-based photobiomodulation in people with MELAS, a mitochondrial disease, comparing active and sham treatment with washout periods. The study is designed to assess safety and changes in fatigue and other symptoms, with the primary outcome being patient-reported fatigue. As a protocol, the abstract reports no results, and the authors state the study will guide whether a larger randomized trial with sham control should proceed.

Who or what was studied
People with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS)
Wavelengths
465, 660, 850 nm
Limits stated in the abstract
The abstract describes a study protocol with no reported results, and the design is exploratory with single-patient trials in a rare disease.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

Background

There is no cure for mitochondrial diseases which manifest in numerous ways including fatigue, muscle weakness, and exercise intolerance. Medical treatment varies and focuses on managing symptoms. Photobiomodulation (PBM) can decrease mitochondrial damage thereby increasing energy production and decreasing cell death. This pilot study will apply PBM to people with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) to examine the safety of application, and if changes occur in symptoms and signs after cross-over application/withdrawal of a sham or active PBM treatment including a two-week period of washout.

Methods

This study is an exploratory, prospective series N-of-1 (single patient) studies. The protocol is guided by the CONSORT extension for reporting N-of-1 trials (CENT 2015), chosen due to the rarity of mitochondrial diseases, the fluctuating symptomology, and heterogeneity of the clinical presentation. The primary outcome is patient-reported fatigue assessed using the Checklist of Individual Strength and with concomitant evaluation of safety. Secondary measures are of depression, anxiety and stress, sleepiness, physical activity, blood lactate and creatine kinase, physical measures of sit-to-stand, and heel raise capability. Mitochondrial function will be evaluated using hydrogen magnetic resonance spectroscopy for lactate. PBM will be a participant-administered, home-based therapy using a multiple diode flexible array (BeniLight iLED-Pro Multi-Wave Multi-Pulse belt; 465 nm, 660 nm, 850 nm; average irradiance 5.23 mW/cm2; total joules: 770.1 J/treatment, all sites; 5 KHz; 20% duty ratio) over the anterior thigh muscles, posterior calf muscles and abdomen for 10 min to each site, three times/week. The safety of the intervention will be assessed. Descriptive statistics, causal analyses of time series data and dynamic modelling will be applied as relevant to the variables collected. Hydrogen magnetic resonance spectra will be acquired and averaged to obtain the content of the targeted hydrogen levels.

Discussion

The study will provide guidance on whether and how to progress to a larger, randomised cohort study with sham control.

Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.

Light parameters mentioned

Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.

Wavelength
465 nm, 660 nm, 850 nm
Power density (irradiance)
5.23 mW/cm2

How to read a single study: what to check before relying on this kind of research.

Terms in this paper: Photobiomodulation, Sham, Primary outcome, Heterogeneity, Pilot study, Depression, Irradiance, Anxiety. Each links to its definition in the glossary.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies